About
We are a group of clinicians dedicated to advancing cancer diagnosis and treatment, Our expertise spans across:
- haematological and medical oncology
- surgery
- paediatrics
- immunology
- histopathology
- radiology
As clinicians, we ensure our research is always focused on improving patient care, and is translated from the laboratory to clinic as rapidly as possible. Our main research areas include:
- cancer immunotherapy
- lymphoma
- breast cancer
- colorectal cancer
- oesophageal cancer
- urology
- neuroblastoma
We work collaboratively with basic discovery scientists and other disciplines, including mathematicians, chemists, statisticians and engineers.
We are based in the University and University Hospital Southampton and work closely with other partners to develop new clinical trials, including:
People, projects, publications and PhDs
People
-
Professor Peter Johnson
Professor of Medical OncologyEmail: johnsonp@soton.ac.ukTel: +44 2381206186 -
Professor Ramsey Cutress
Professor of Breast SurgeryEmail: R.I.Cutress@soton.ac.ukTel: +000 -
Professor Sean Lim
Professor of HaematologyIdentification of new therapeutic targets in lymphoma
Accepting applications from PhD studentsEmail: S.H.Lim@soton.ac.ukTel: +44 2381205627 -
Professor Simon Crabb
Professor of Experimental Cancer TherapeuticsBladder cancer
Prostate cancer
Predictive biomarkers
Email: S.J.Crabb@southampton.ac.ukTel: +44 2381205558 -
Professor Tim Underwood
Professor of Gastrointestinal SurgeryEmail: T.J.Underwood@soton.ac.uk -
Professor Tony Williams
Professor of Translational MedicineEmail: A.P.Williams@soton.ac.ukTel: +44 2381208059
Pagination
Related research institutes, centres and groups
-
Centre for Cancer Immunology
The Centre for Cancer Immunology's interdisciplinary research helps scientists and medics to collaborate worldwide. By bringing people together and sharing our expertise, we're working faster than ever before towards a cure for cancer. -
Southampton Clinical Trials Unit (SCTU)
We deliver world-leading clinical trials of innovative new treatments and diagnostic tools. Our trials directly influence routine clinical practice for the benefit of patients. -
Antibody and Vaccine Group
We are a collaborative group of about 60 scientists and clinician scientists working to a common goal: how to harness the immune system to cure cancer.